Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
**MBLX** Metabolix Conference/Presentation today
(GLOBE NEWSWIRE) -- Metabolix, Inc. (MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it will present its latest findings on the multifunctional benefits of bio-based PHA copolymers in a range of applications for polyvinyl chloride (PVC) and wood polymer composites. The new findings will be a key part of a technical presentation, entitled “Bio-based PHA Copolymers as Multifunctional Additives for Poly Vinyl Chloride Compound,” to be delivered by Mansoor Akhthar, Metabolix application development manager - PVC, at the upcoming Vinyltec 2015 conference Oct.13-15 in Akron, Ohio.
New research is leading to the development and commercialization of PHA biopolymer technology that improves processing and performance characteristics in a range of PVC applications including flexible, semi-rigid and wood polymer composites, particularly when high levels of fillers and PVC recyclate are incorporated. Among the findings, Metabolix has shown that its PHA biopolymers – highly miscible in PVC – can be used as process aids that act as both a lubricant and fusion aid with a resulting reduction in machine torque to increase ease of processing. The use of PHA also allows the increased use of mineral fillers, wood flour or PVC recyclate with improved properties of the final parts. Another key finding is that all of these performance and processing advantages can deliver significant cost improvements.
“Our PHA biopolymers display a set of unique performance properties in PVC formulations and represent a significant innovation in the industry,” said Max Senechal, Metabolix’s vice president of strategy and commercial development. “Our PHA biopolymers offer a range of processing and performance improvements while also delivering an economic benefit to PVC converters and brand owners. We look forward to continuing to work with the industry to create new solutions for PVC applications in a diverse range of building materials.”
Report TOS
**MBLX** Metabolix Conference/Presentation today
(GLOBE NEWSWIRE) -- Metabolix, Inc. (MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it will present its latest findings on the multifunctional benefits of bio-based PHA copolymers in a range of applications for polyvinyl chloride (PVC) and wood polymer composites. The new findings will be a key part of a technical presentation, entitled “Bio-based PHA Copolymers as Multifunctional Additives for Poly Vinyl Chloride Compound,” to be delivered by Mansoor Akhthar, Metabolix application development manager - PVC, at the upcoming Vinyltec 2015 conference Oct.13-15 in Akron, Ohio.
New research is leading to the development and commercialization of PHA biopolymer technology that improves processing and performance characteristics in a range of PVC applications including flexible, semi-rigid and wood polymer composites, particularly when high levels of fillers and PVC recyclate are incorporated. Among the findings, Metabolix has shown that its PHA biopolymers – highly miscible in PVC – can be used as process aids that act as both a lubricant and fusion aid with a resulting reduction in machine torque to increase ease of processing. The use of PHA also allows the increased use of mineral fillers, wood flour or PVC recyclate with improved properties of the final parts. Another key finding is that all of these performance and processing advantages can deliver significant cost improvements.
“Our PHA biopolymers display a set of unique performance properties in PVC formulations and represent a significant innovation in the industry,” said Max Senechal, Metabolix’s vice president of strategy and commercial development. “Our PHA biopolymers offer a range of processing and performance improvements while also delivering an economic benefit to PVC converters and brand owners. We look forward to continuing to work with the industry to create new solutions for PVC applications in a diverse range of building materials.”
Report TOS
Mezaun Norman what a JOKE
Amazing how she pulled another fast one- what an absolute disgrace and shame. Can only imagine how much they profited from the Verizon fiasco they pumped
$5-$7 **MBLX** Metabolix Conference/Presentation today
(GLOBE NEWSWIRE) -- Metabolix, Inc. (MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it will present its latest findings on the multifunctional benefits of bio-based PHA copolymers in a range of applications for polyvinyl chloride (PVC) and wood polymer composites. The new findings will be a key part of a technical presentation, entitled “Bio-based PHA Copolymers as Multifunctional Additives for Poly Vinyl Chloride Compound,” to be delivered by Mansoor Akhthar, Metabolix application development manager - PVC, at the upcoming Vinyltec 2015 conference Oct.13-15 in Akron, Ohio.
New research is leading to the development and commercialization of PHA biopolymer technology that improves processing and performance characteristics in a range of PVC applications including flexible, semi-rigid and wood polymer composites, particularly when high levels of fillers and PVC recyclate are incorporated. Among the findings, Metabolix has shown that its PHA biopolymers – highly miscible in PVC – can be used as process aids that act as both a lubricant and fusion aid with a resulting reduction in machine torque to increase ease of processing. The use of PHA also allows the increased use of mineral fillers, wood flour or PVC recyclate with improved properties of the final parts. Another key finding is that all of these performance and processing advantages can deliver significant cost improvements.
“Our PHA biopolymers display a set of unique performance properties in PVC formulations and represent a significant innovation in the industry,” said Max Senechal, Metabolix’s vice president of strategy and commercial development. “Our PHA biopolymers offer a range of processing and performance improvements while also delivering an economic benefit to PVC converters and brand owners. We look forward to continuing to work with the industry to create new solutions for PVC applications in a diverse range of building materials.”
Report TOS
** MBLX** Metabolix Conference/Presentation today
(GLOBE NEWSWIRE) -- Metabolix, Inc. (MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it will present its latest findings on the multifunctional benefits of bio-based PHA copolymers in a range of applications for polyvinyl chloride (PVC) and wood polymer composites. The new findings will be a key part of a technical presentation, entitled “Bio-based PHA Copolymers as Multifunctional Additives for Poly Vinyl Chloride Compound,” to be delivered by Mansoor Akhthar, Metabolix application development manager - PVC, at the upcoming Vinyltec 2015 conference Oct.13-15 in Akron, Ohio.
New research is leading to the development and commercialization of PHA biopolymer technology that improves processing and performance characteristics in a range of PVC applications including flexible, semi-rigid and wood polymer composites, particularly when high levels of fillers and PVC recyclate are incorporated. Among the findings, Metabolix has shown that its PHA biopolymers – highly miscible in PVC – can be used as process aids that act as both a lubricant and fusion aid with a resulting reduction in machine torque to increase ease of processing. The use of PHA also allows the increased use of mineral fillers, wood flour or PVC recyclate with improved properties of the final parts. Another key finding is that all of these performance and processing advantages can deliver significant cost improvements.
“Our PHA biopolymers display a set of unique performance properties in PVC formulations and represent a significant innovation in the industry,” said Max Senechal, Metabolix’s vice president of strategy and commercial development. “Our PHA biopolymers offer a range of processing and performance improvements while also delivering an economic benefit to PVC converters and brand owners. We look forward to continuing to work with the industry to create new solutions for PVC applications in a diverse range of building materials.”
** MBLX** Metabolix Conference/Presentation today
(GLOBE NEWSWIRE) -- Metabolix, Inc. (MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced that it will present its latest findings on the multifunctional benefits of bio-based PHA copolymers in a range of applications for polyvinyl chloride (PVC) and wood polymer composites. The new findings will be a key part of a technical presentation, entitled “Bio-based PHA Copolymers as Multifunctional Additives for Poly Vinyl Chloride Compound,” to be delivered by Mansoor Akhthar, Metabolix application development manager - PVC, at the upcoming Vinyltec 2015 conference Oct.13-15 in Akron, Ohio.
New research is leading to the development and commercialization of PHA biopolymer technology that improves processing and performance characteristics in a range of PVC applications including flexible, semi-rigid and wood polymer composites, particularly when high levels of fillers and PVC recyclate are incorporated. Among the findings, Metabolix has shown that its PHA biopolymers – highly miscible in PVC – can be used as process aids that act as both a lubricant and fusion aid with a resulting reduction in machine torque to increase ease of processing. The use of PHA also allows the increased use of mineral fillers, wood flour or PVC recyclate with improved properties of the final parts. Another key finding is that all of these performance and processing advantages can deliver significant cost improvements.
“Our PHA biopolymers display a set of unique performance properties in PVC formulations and represent a significant innovation in the industry,” said Max Senechal, Metabolix’s vice president of strategy and commercial development. “Our PHA biopolymers offer a range of processing and performance improvements while also delivering an economic benefit to PVC converters and brand owners. We look forward to continuing to work with the industry to create new solutions for PVC applications in a diverse range of building materials.”
***GDSI*** flying!!! low float- multi bagged ahead- global digital
I'm not concerned about a quick flip here or day trading....
I'll hold and get my 3-4 fold gains from these levels...
Patience little grasshopper- you see how tight and low the float is- they need to increase positions prior to them igniting this. Just keep an eye on this and remember where it is right now
It'll get their quickly again you'll see
Bleed out the week and profit takers and they'll ramp this up with ease
***GDSI*** up 70% low float- multi bagged ahead- global digital
***GDSI*** up 70% low float- multi bagged ahead- global digital
Once 0025 is broken watch for a major spike and run
Watch
Penny land ahead!!!!
GDSI flying!! Low float and moving up nice
***GDSI*** 300%+ today Global Digital!! Low float will spike up here big time
GDSI
***GDSI*** 300%+ today Global Digital!! Low float will spike up here big time
GDSI
Should see 150-200%+ today
Should see .004-.005 super thin float
***GDSI*** 300%+ today Global Digital!!
GDSI
***GDSI*** 300%+ today Global Digital!!
GDSI
**XNPT** Xenoport- Primary Endpoints- psoriasis drug!!!
**XNPT** Xenoport- Primary Endpoints- psoriasis drug!!!
**XNPT** Xenoport- Primary Endpoints- psoriasis drug!!!
VLTC and Carl Icahn- could see $12-$14 outright buyout here
Voltari
Eyes on VLTC- Voltari and Carl Icahn
$$$$$
VLTC- long time now- expecting Carl to make a move $12-$15
VLTC and Carl Icahn- could see $12-$14 outright buyout here
Voltari
VLTC and Carl Icahn- could see $12-$14 outright buyout here
Voltari
**COLL** FDA Approval!!! Unanimous decision.
Collegium Pharma - Xtampza
$25+++ targets this week
**COLL** FDA Approval!!! Unanimous decision.
Collegium Pharma - Xtampza
$25+++ targets this week
**COLL** FDA Approval!!! Unanimous decision.
Collegium Pharma - Xtampza
$25+++ targets this week
**COLL** FDA Approval!!! Unanimous decision.
Collegium Pharma - Xtampza
$25+++ targets this week
**COLL** FDA Approval!!! Unanimous decision.
Collegium Pharma - Xtampza
$25+++ targets this week
**COLL** FDA Approval!!! Unanimous decision.
Collegium Pharma - Xtampza
$25+++ targets this week
**COLL** FDA Approval!!! Unanimous decision.
Collegium Pharma - Xtampza
**COLL** FDA Approval!!! Unanimous decision.
Collegium Pharma - Xtampza
**COLL** FDA Approval!!!
Collegium Pharma
**COLL** FDA Approval!!!
Collegium Pharma
VLTC- Blast off time!!!!!! Carl Icahn all over this
Voltari